ArticleBioengineered2021

Up-regulation of S100P predicts the poor long-term survival and construction of prognostic signature for survival and immunotherapy in patients with pancreatic cancer.

Wenbo Zou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.